MedDataX Logo

Continuous Regional Analgesia After Total Knee Arthroplasty

NCT ID: NCT00337597

Last Updated: 2008-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-05-31

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective, comparative and double blind study is aimed to determine if normal saline or dextrose 5% in water will modify the stimulation during the insertion of the stimulating catheter used for continuous femoral and sciatic blocks in total knee replacement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The operator is blinded to the medium fluid to expand the perineural femoral and sciatic nerves before threading in the stimulating catheter. He records all the electric data of electrolocation of nerve, which will be compared to determine whether or not a difference in intensity is found between normal saline or dextrose 5% in water.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Normal saline Dextrose 5% in water neurostimulation Continuous regional analgesia after total knee arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Glucose 5%

Intervention Type OTHER

NaCl 0.9%

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologists (ASA) I and II
* Male or non-pregnant female
* 18 - 80 years of age
* Not allergic to iodine or local anesthetics
* Absence of abnormality of coagulation
* Scheduled for total knee replacement
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nantes University Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Charles Pham Dang, MD

Role: PRINCIPAL_INVESTIGATOR

Nantes UH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Departemental Hospital of la Roche sur Yon

La Roche-sur-Yon, , France

Site Status

Nantes University Hospital

Nantes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BRD 05/7-F

Identifier Type: -

Identifier Source: org_study_id